why choose us

First received: March 05, 2024

Clinical Trial: SVF for Treating Pulmonary Fibrosis Post COVID-19

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pulmonary Fibrosis

Study Type: INTERVENTIONAL


Official Title: The Role of Cellular Therapy With SVF Cells (Stromal Vascular Fraction) of Adipose Tissue Origin in the Treatment of Pulmonary Fibrosis Post COVD-19

Brief Summary: General description of the studyThis is a prospective, multicenter, expanded access interventional study of subjects recovered from COVID-19 pneumonia to assess their response to intravenous administration of adipose-derived autologous SVF.Primary objectiveThe purpose of this study was to evaluate the safety of single intravenous injections of autologous adipose-derived SVF produced using the GID SVF-2 device system for the treatment of secondary respiratory distress associated with COVID-19.Secondary objectiveTo…

Read more